TERNS PHARMACEUTICALS INC (TERN) Stock News

USA - NASDAQ:TERN - US8808811074 - Common Stock

7.77 USD

+0.27 (+3.6%)

Last: 10/24/2025, 8:00:01 PM

7.77 USD

0 (0%)

After Hours: 10/24/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

TERN Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Chartmill - Mentions: MSN ISRG PEGA MANH ...

News Image

Which stocks are moving after the closing bell on Tuesday?

3 days ago - By: Benzinga

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?

4 days ago - By: Benzinga - Mentions: NFLX ALM TXN GNPX ...

Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

23 days ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

23 days ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

a month ago - By: The Motley Fool - Mentions: RYTM

2 Under-the-Radar Stocks That Could Soar

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

3 months ago - By: The Motley Fool

Terns (TERN) Q2 Net Loss Narrows 16%

3 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

3 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

3 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

3 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

4 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

4 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

5 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

5 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

5 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

5 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

6 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

6 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

6 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

6 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

6 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

6 months ago - By: Bloomberg - Mentions: PFE VKTX GPCR MTSR

Pfizer Setback Spurs Rise in Obesity Developers on M&A Hopes

7 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

7 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

7 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates